End to End OpAns offers integrated research, development and personalized testing to shorten project timelines and reduce vendor handoffs, enabling pharma and biotech clients to pursue end-to-end CRO partnerships across discovery and clinical testing.

Pediatric Micro Sampling The patented amasse dried bio-fluid specimen device plus focus on pediatric trials enables minimally invasive sampling and potential at-home collection, creating sales opportunities with pediatric studies, hospitals and clinics.

Govt and Regulated Proven experience supporting EPA, NIH and NCATS, along with environmental screening programs like TOX21, ToxCast and EDSP, positions OpAns to win government and regulated market contracts requiring validated toxicology and bioanalytical services.

Mass Spectrometry Strength in mass spectrometry based bioanalysis including PK, PD, biomarker quantification and ADME enables competitive bids for drug discovery, regulatory submissions and clinical diagnostics projects.

Secure Data HIPAA compliant operations, Azure cloud capabilities and a modern tech stack support scalable, secure handling of sensitive patient data, a strong differentiator when selling to hospitals, clinics and regulated CRO customers.